Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (SHA:600332)
China
· Delayed Price · Currency is CNY 25.17
+0.01 (0.04%)
At close: Mar 9, 2026
SHA:600332 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 38,966 | 43,716 | 44,550 | 46,355 | 52,103 | 44,644 | Upgrade
|
| Market Cap Growth | -7.17% | -1.87% | -3.90% | -11.03% | 16.71% | -19.26% | Upgrade
|
| Enterprise Value | 38,810 | 42,083 | 38,614 | 38,377 | 40,977 | 36,208 | Upgrade
|
| Last Close Price | 25.17 | 27.57 | 26.69 | 27.18 | 30.52 | 25.63 | Upgrade
|
| PE Ratio | 13.70 | 15.42 | 10.99 | 11.69 | 14.01 | 15.31 | Upgrade
|
| Forward PE | 13.45 | 13.11 | 10.47 | 12.61 | 14.55 | 13.46 | Upgrade
|
| PS Ratio | 0.50 | 0.58 | 0.59 | 0.66 | 0.76 | 0.72 | Upgrade
|
| PB Ratio | 0.97 | 1.16 | 1.22 | 1.38 | 1.66 | 1.58 | Upgrade
|
| P/TBV Ratio | 1.14 | 1.36 | 1.43 | 1.62 | 2.03 | 1.95 | Upgrade
|
| P/FCF Ratio | 39.11 | 18.89 | 18.00 | 8.26 | 11.79 | - | Upgrade
|
| P/OCF Ratio | 17.54 | 12.70 | 10.86 | 6.62 | 9.18 | 76.29 | Upgrade
|
| PEG Ratio | 2.38 | 3.58 | 3.58 | 3.58 | 3.58 | 3.58 | Upgrade
|
| EV/Sales Ratio | 0.50 | 0.56 | 0.51 | 0.54 | 0.59 | 0.59 | Upgrade
|
| EV/EBITDA Ratio | 8.64 | 10.34 | 7.07 | 7.67 | 9.33 | 10.60 | Upgrade
|
| EV/EBIT Ratio | 10.46 | 12.11 | 8.05 | 8.55 | 10.32 | 11.96 | Upgrade
|
| EV/FCF Ratio | 38.95 | 18.18 | 15.60 | 6.84 | 9.27 | - | Upgrade
|
| Debt / Equity Ratio | 0.40 | 0.37 | 0.33 | 0.36 | 0.32 | 0.34 | Upgrade
|
| Debt / EBITDA Ratio | 3.59 | 3.23 | 2.09 | 2.30 | 2.14 | 2.60 | Upgrade
|
| Debt / FCF Ratio | 16.16 | 6.01 | 4.83 | 2.14 | 2.25 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.06 | -0.23 | -0.28 | -0.38 | -0.40 | -0.35 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.53 | -2.17 | -1.85 | -2.53 | -2.84 | -2.92 | Upgrade
|
| Net Debt / FCF Ratio | -2.24 | -3.81 | -4.08 | -2.25 | -2.82 | 34.20 | Upgrade
|
| Asset Turnover | 0.96 | 0.94 | 0.99 | 1.01 | 1.10 | 1.06 | Upgrade
|
| Inventory Turnover | 5.77 | 5.14 | 5.53 | 5.45 | 5.53 | 5.33 | Upgrade
|
| Quick Ratio | 1.15 | 1.11 | 1.17 | 1.20 | 1.27 | 1.23 | Upgrade
|
| Current Ratio | 1.60 | 1.48 | 1.55 | 1.53 | 1.64 | 1.62 | Upgrade
|
| Return on Equity (ROE) | 7.97% | 8.06% | 12.12% | 13.09% | 13.33% | 11.41% | Upgrade
|
| Return on Assets (ROA) | 2.85% | 2.71% | 3.91% | 3.98% | 3.94% | 3.24% | Upgrade
|
| Return on Invested Capital (ROIC) | 8.39% | 10.41% | 16.80% | 18.98% | 17.98% | 15.46% | Upgrade
|
| Return on Capital Employed (ROCE) | 8.20% | 8.10% | 11.30% | 12.00% | 11.70% | 9.90% | Upgrade
|
| Earnings Yield | 7.66% | 6.49% | 9.10% | 8.56% | 7.14% | 6.53% | Upgrade
|
| FCF Yield | 2.56% | 5.29% | 5.56% | 12.11% | 8.48% | -0.65% | Upgrade
|
| Dividend Yield | 3.18% | 2.90% | 2.81% | 2.69% | 2.25% | 2.10% | Upgrade
|
| Payout Ratio | 77.85% | 79.38% | 39.09% | 37.58% | 34.03% | 44.25% | Upgrade
|
| Buyback Yield / Dilution | -0.01% | -0.02% | 0.02% | - | - | - | Upgrade
|
| Total Shareholder Return | 3.17% | 2.88% | 2.82% | 2.69% | 2.25% | 2.10% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.